These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18403776)

  • 1. Platelet activation and atherothrombosis.
    Kapoor JR
    N Engl J Med; 2008 Apr; 358(15):1638; author reply 1638-9. PubMed ID: 18403776
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
    Simmons BB; Salzman BE
    J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
    [No Abstract]   [Full Text] [Related]  

  • 3. Prasugrel versus clopidogrel.
    von Lewinski F; Riggert J; Paulus W
    N Engl J Med; 2008 Mar; 358(12):1299; author reply 1299-301. PubMed ID: 18357639
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
    Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
    Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Attack on many vascular fronts. Atherothrombosis trouble seldom comes alone].
    MMW Fortschr Med; 2004; 146 Suppl 1():4-5. PubMed ID: 15493408
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contribution of platelet aggregation inhibitors in the prevention of complications of atherothrombosis].
    Guilmot JL; Diot E; Gruel Y
    Presse Med; 2000 Apr; 29(13):709-16. PubMed ID: 10797825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract]   [Full Text] [Related]  

  • 8. Clopidogrel: a review of its use in the prevention of atherothrombosis.
    Jarvis B; Simpson K
    Drugs; 2000 Aug; 60(2):347-77. PubMed ID: 10983738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facts and controversies of aspirin and clopidogrel therapy.
    Faxon DP; Freedman JE
    Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensifying platelet inhibition--navigating between Scylla and Charybdis.
    Bhatt DL
    N Engl J Med; 2007 Nov; 357(20):2078-81. PubMed ID: 17982183
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial).
    Cannon CP;
    Am J Cardiol; 2002 Oct; 90(7):760-2. PubMed ID: 12356393
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet therapy for ischemic heart disease.
    Steimle AE
    N Engl J Med; 2004 May; 350(20):2101-2; author reply 2101-2. PubMed ID: 15141055
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond aspirin.
    Harv Heart Lett; 1998 Jun; 8(10):1-3. PubMed ID: 9619133
    [No Abstract]   [Full Text] [Related]  

  • 16. 2 drugs team up for protection. Old standby joins relative newcomer to battle heart disease.
    Heart Advis; 2003 Aug; 6(8):3. PubMed ID: 15114971
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
    Rupprecht HJ
    MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiplatelet therapy for atherothrombotic disease: an update for the primary care physician.
    Kikano GE; Brown MT
    Mayo Clin Proc; 2007 May; 82(5):583-93. PubMed ID: 17511957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vorapaxar: A Protease-Activated Receptor Antagonist for the Prevention of Thrombotic Events.
    Lam S; Tran T
    Cardiol Rev; 2015; 23(5):261-7. PubMed ID: 25923910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.